Bart De Strooper receives prestigious USD 200,000 Alzheimer Prize
Bart De Strooper (VIB, K.U.Leuven) has been playing a prominent role in researching the processes that underlie Alzheimer's disease. He has received widespread recognition for his work, both nationally and internationally and he received the MetLife Foundation's USD 200,000 Alzheimer Prize. This prestigious prize is awarded to emphasize the importance of fundamental research on Alzheimer's disease and highlights the significance of De Strooper's research in the quest for a cure.
For years now, Bart De Strooper has been conducting pioneering research on Alzheimer's disease. He has discovered important mechanisms that lead to this disorder and has uncovered the central role that presenilin plays in the onset of the disease. This finding was the impetus for the global search for remedies. Since then, Bart De Strooper and his research team have continued to unravel the disease processes even further in the ongoing quest for new therapies.
Since 1986, MetLife Foundation has awarded major prizes to scientists who have made significant contributions to a better understanding of Alzheimer's disease. This award program is based on a very strong belief in the importance of fundamental research and the freedom of scientists to pursue their ideas. Along with Robert J. Vassar (Northwestern University, Chicago) and Philip C. Wong (the John Hopkins University School of Medicine), Bart De Strooper is receiving the MetLife Foundation Prize 2008. Each of them will receive USD 200,000.
Other news from the department science
